-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 O3NQIn3B7FISjwPZFPu23q0+lXB7S/oeEKI4aAWqunuu36uVYox2IrQDZDe1Nfxm
 Q/IwvHBpFjrgb2sAyKiOUw==

<SEC-DOCUMENT>0001209191-08-005478.txt : 20080124
<SEC-HEADER>0001209191-08-005478.hdr.sgml : 20080124
<ACCEPTANCE-DATETIME>20080124194751
ACCESSION NUMBER:		0001209191-08-005478
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080124
FILED AS OF DATE:		20080124
DATE AS OF CHANGE:		20080124

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACURA PHARMACEUTICALS, INC
		CENTRAL INDEX KEY:			0000786947
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				110853640
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		616 N. NORTH COURT, SUITE 120
		CITY:			PALATINE
		STATE:			IL
		ZIP:			60067
		BUSINESS PHONE:		847-705-7709

	MAIL ADDRESS:	
		STREET 1:		616 N. NORTH COURT, SUITE 120
		STREET 2:		.
		CITY:			PALATINE
		STATE:			IL
		ZIP:			60067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALSEY DRUG CO INC/NEW
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SKELLY WILLIAM G
		CENTRAL INDEX KEY:			0001058352

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10113
		FILM NUMBER:		08548957

	BUSINESS ADDRESS:	
		STREET 1:		C/O CENTRAL BIOMEDIA
		STREET 2:		9900 PFLUMM
		CITY:			LENEXA
		STATE:			KS
		ZIP:			64155
		BUSINESS PHONE:		(847) 705-7709

	MAIL ADDRESS:	
		STREET 1:		C/O ACURA PHARMACEUTICALS, INC.
		STREET 2:		616 N. NORTH COURT, SUITE 120
		CITY:			PALATINE
		STATE:			IL
		ZIP:			60067
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-01-24</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000786947</issuerCik>
        <issuerName>ACURA PHARMACEUTICALS, INC</issuerName>
        <issuerTradingSymbol>ACPH</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001058352</rptOwnerCik>
            <rptOwnerName>SKELLY WILLIAM G</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ACURA PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>616 N. NORTH COURT</rptOwnerStreet2>
            <rptOwnerCity>PALATINE</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60067</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Director Stock Options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.50</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-01-24</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>15000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-01-23</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>15000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>15000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Exercise price is  last sale price on January 24, 2008 as reported on the OTCBB.</footnote>
        <footnote id="F2">One-quarter of shares underlying options vest on, and are exercisable commencing, each of March 31, 2008, June 30, 2008, September 30, 2008 and December 31, 2008.</footnote>
        <footnote id="F3">Not Applicable.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ William Skelly</signatureName>
        <signatureDate>2008-01-24</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----